Advanced oxidation protein products activate intrarenal renin-angiotensin system via a CD36-mediated, redox-dependent pathway

Antioxidants and Redox Signaling

Volumn 18, Issue 1, 2013, Pages 19-35

  Cao, Wei ^a   Xu, Jie ^a   Zhou, Zhan Mei ^a   Wang, Guo Bao ^a   Hou, Fan Fan ^a   Nie, Jing ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; ALBUMIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSINOGEN; CD36 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE C ALPHA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SMALL INTERFERING RNA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; UNINEPHRECTOMY; UPREGULATION; URINARY EXCRETION;

ADVANCED OXIDATION PROTEIN PRODUCTS; ANGIOTENSINOGEN; ANIMALS; ANTIGENS, CD36; CARBAZOLES; CELL LINE; EPITHELIAL CELLS; HUMANS; KIDNEY; KIDNEY TUBULES, PROXIMAL; MALE; MICE; NADPH OXIDASE; NF-KAPPA B; OXIDATION-REDUCTION; PEPTIDYL-DIPEPTIDASE A; PROTEIN KINASE C-ALPHA; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; RENAL INSUFFICIENCY; RENIN-ANGIOTENSIN SYSTEM; SERUM ALBUMIN; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; UP-REGULATION;

RATTUS;

EID: 84870510806     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4603     Document Type: Article

References (49)

1. Camilla R, Suzuki H, Dapra V, Loiacono E, Peruzzi L, Amore A, Ghiggeri GM, Mazzucco G, Scolari F, Gharavi AG, Appel GB, Troyanov S, Novak J, Julian BA, and Coppo R. Oxidative stress and galactose-deficient IgA1 as markers of progression in IgA nephropathy. Clin J Am Soc Nephrol 6: 1903-1911, 2011.
2. Cao W, Zhou QG, Nie J, Wang GB, Liu Y,Zhou ZM, and Hou FF. Albumin overload activates intrarenal renin-angiotensin system through protein kinase C and NADPH oxidase-dependent pathway. J Hypertens 29: 1411-1421, 2011.
3. Casas JP, Chua W, Loukogeorgakis S, Vallance P, Smeeth L, Hingorani AD, and MacAllister RJ. Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 366: 2026-2033, 2005.
4. Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, Nguyen AT, Gausson V, Mothu N, Cardoso C, Noel LH, Guerin AP, London GM, and Jungers P. Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers. Kidney Int 66: 1606-1612, 2004.
5. Dong L, Stevens JL, Fabbro D, and Jaken S. Protein kinase C isozyme expression and down-modulation in growing, quiescent, and transformed renal proximal tubule epithelial cells. Cell Growth Differ 5: 881-890, 1994.
6. Elton TS and Martin MM. Angiotensin II type 1 receptor gene regulation: transcriptional and posttranscriptional mechanisms. Hypertension 49: 953-961, 2007.
7. Eyries M, Agrapart M, Alonso A, and Soubrier F. Phorbol ester induction of angiotensin-converting enzyme transcription is mediated by Egr-1 and AP-1 in human endo-thelial cells via ERK1/2 pathway. Circ Res 91: 899-906, 2002.
8. Ge J, Jia Q, Liang C, Luo Y, Huang D, Sun A, Wang K, Zou Y, and Chen H. Advanced glycosylation end products might promote atherosclerosis through inducing the immune maturation of dendritic cells. Arterioscler Thromb Vasc Biol 25: 2157-2163, 2005.
9. Graciano ML, Cavaglieri Rde C, Delle H, Dominguez WV, Casarini DE, Malheiros DM, and Noronha IL. Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J Am Soc Nephrol 15: 1805-1815, 2004.
10. Grden M, Podgorska M, Kocbuch K, Rzepko R, Szutowicz A, and Pawelczyk T. High glucose suppresses expression of equilibrative nucleoside transporter 1 (ENT1) in rat cardiac fibroblasts through a mechanism dependent on PKC-zeta and MAP kinases. J Cell Physiol 215: 151-160, 2008.
11. Grone HJ, Grone EF, and Malle E. Immunohistochemical detection of hypochlorite-modified proteins in glomeruli of human membranous glomerulonephritis. Lab Invest 82: 5-14, 2002.
12. Guo X, Wang L, Chen B, Li Q, Wang J, Zhao M, Wu W, Zhu P, Huang X, and Huang Q. ERM protein moesin is phos-phorylated by advanced glycation end products and modulates endothelial permeability. Am J Physiol Heart Circ Physiol 297: H238-H246, 2009.
13. Guo ZJ, Niu HX, Hou FF, Zhang L, Fu N, Nagai R, Lu X, Chen BH, Shan YX, Tian JW, Nagaraj RH, Xie D, and Zhang X. Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway. Antioxid Redox Signal 10: 1699-1712, 2008.
14. Helal I, Fick-Brosnahan GM, Reed-Gitomer B, and Schrier RW. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol 8: 293-300, 2012.
15. Henriksen EJ, Diamond-Stanic MK, and Marchionne EM. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med 51: 993-999, 2011.
16. Hou FF, Xie D, Zhang X, Chen PY, Zhang WR, Liang M, Guo ZJ, and Jiang JP. Renoprotection of Optimal Anti-proteinuric Doses (ROAD) Study: a randomized controlled study of benazepril and losartan in chronic renal insufficiency. J Am Soc Nephrol 18: 1889-1898, 2007.
17. Hou FF, Zhang X, Zhang GH, Xie D, Chen PY, Zhang WR, Jiang JP, Liang M, Wang GB, Liu ZR, and Geng RW. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med 354: 131-140, 2006.
18. Hsieh TJ, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, and Chan JS. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology 143: 2975-2985, 2002.
19. Ingelfinger JR, Zuo WM, Fon EA, Ellison KE, and Dzau VJ. In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J Clin Invest 85: 417-423, 1990.
20. Iwao Y, Nakajou K, Nagai R, Kitamura K, Anraku M, Maruyama T, and Otagiri M. CD36 is one of important receptors promoting renal tubular injury by advanced oxidation protein products. Am J Physiol Renal Physiol 295: F1871-F1880, 2008.
21. Jamaluddin M, Meng T, Sun J, Boldogh I, Han Y, and Brasier AR. Angiotensin II induces nuclear factor (NF)-kappaB1 isoforms to bind the angiotensinogen gene acute-phase response element: a stimulus-specific pathway for NF-kappaB activation. Mol Endocrinol 14: 99-113, 2000.
22. Kalousova M, Skrha J, and Zima T. Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 51: 597-604, 2002.
23. Kobori H, Nangaku M, Navar LG, and Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59: 251-287, 2007.
24. Kobori H, Nishiyama A, Abe Y, and Navar LG. Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 41: 592-597, 2003.
25. Largo R, Gomez-Garre D, Soto K, Marron B, Blanco J, Gazapo RM, Plaza JJ, and Egido J. Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. Hypertension 33: 732-739, 1999.
26. Li HY, Hou FF, Zhang X, Chen PY, Liu SX, Feng JX, Liu ZQ, Shan YX, Wang GB, Zhou ZM, Tian JW, and Xie D. Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model. J Am Soc Nephrol 18: 528-538, 2007.
27. Liu B, Hou X, Zhou Q, Tian J, Zhu P, Xu J, Hou F, and Fu N. Detection of advanced oxidation protein products in patients with chronic kidney disease by a novel monoclonal antibody. Free Radic Res 45: 662-671, 2011.
28. Liu D, Gao L, Roy SK, Cornish KG, and Zucker IH. Neu-ronal angiotensin II type 1 receptor upregulation in heart failure: activation of activator protein 1 and Jun N-terminal kinase. Circ Res 99: 1004-1011, 2006.
29. Malle E, Woenckhaus C, Waeg G, Esterbauer H, Grone EF, and Grone HJ. Immunological evidence for hypochlorite-modified proteins in human kidney. Am J Pathol 150: 603-615, 1997.
30. Martin-Gallan P, Carrascosa A, Gussinye M, and Dom-inguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 34: 1563-1574, 2003.
31. Nishiyama A, Seth DM, and Navar LG. Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension 39: 129-134, 2002.
32. Nowak G. Protein kinase C-alpha and ERK1/2 mediate mitochondrial dysfunction, decreases in active Na + transport, and cisplatin-induced apoptosis in renal cells. J Biol Chem 277: 43377-43388, 2002.
33. Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, and Himmelfarb J. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 65: 1009-1016, 2004.
34. Pandey KB, Mishra N, and Rizvi SI. Protein oxidation bio-markers in plasma of type 2 diabetic patients. Clin Biochem 43: 508-511, 2010.
35. Piwowar A, Knapik-Kordecka M, and Warwas M. AOPP and its relations with selected markers of oxidative/anti-oxidative system in type 2 diabetes mellitus. Diabetes Res Clin Pract 77: 188-192, 2007.
36. Ruster C and Wolf G. Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol 17: 2985-2991, 2006.
37. Seikaly MG, Arant BS, Jr., and Seney FD, Jr. Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat. J Clin Invest 86: 1352-1357, 1990.
38. Shah SV, Baliga R, Rajapurkar M, and Fonseca VA. Oxidants in chronic kidney disease. J Am Soc Nephrol 18: 16-28, 2007.
39. Shi XY, Hou FF, Niu HX, Wang GB, Xie D, Guo ZJ, Zhou ZM, Yang F, Tian JW, and Zhang X. Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine di-nucleotide phosphate oxidase. Endocrinology 149: 1829-1839, 2008.
40. Takase O, Marumo T, Imai N, Hirahashi J, Takayanagi A, Hishikawa K, Hayashi M, Shimizu N, Fujita T, and Saruta T. NF-kappaB-dependent increase in intrarenal angiotensin II induced by proteinuria. Kidney Int 68: 464-473, 2005.
41. Takase O, Minto AW, Puri TS, Cunningham PN, Jacob A, Hayashi M, and Quigg RJ. Inhibition of NF-kappaB-dependent Bcl-xL expression by clusterin promotes albumin-induced tubular cell apoptosis. Kidney Int 73: 567-577, 2008.
42. Uhal BD, Zhang H, Abdul-Hafez A, Shu R, and Li X. Amiodarone induces angiotensinogen gene expression in lung alveolar epithelial cells through activation protein-1. Basic Clin Pharmacol Toxicol 100: 59-66, 2007.
43. Wei XF, Zhou QG, Hou FF, Liu BY, and Liang M. Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase. Am J Physiol Renal Physiol 296: F427-F437, 2009.
44. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, Jungers P, and Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49: 1304-1313, 1996.
45. Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillere-Blandin C, Nguyen AT, Canteloup S, Dayer JM, Jungers P, Drueke T, and Descamps-Latscha B. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161: 2524-2532, 1998.
46. Wright JT, Jr., Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD, Middleton JP, and Rostand SG. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288: 2421-2431, 2002.
47. Yao LP, Li XX, Yu PY, Xu J, Asico LD, and Jose PA. Dopa-mine D1 receptor and protein kinase C isoforms in spontaneously hypertensive rats. Hypertension 32: 1049-1053, 1998.
48. Zhou LL, Hou FF, Wang GB, Yang F, Xie D, Wang YP, and Tian JW. Accumulation of advanced oxidation protein products induces podocyte apoptosis and deletion through NADPH-dependent mechanisms. Kidney Int 76: 1148-1160, 2009.
49. Zhu P, Tang L, Zhao SC, Lu X, Hou FF, and Fu N. Preparation of monoclonal antibodies against different epitopes on extracellular domain of human receptor for advanced glycation end product. Di Yi Jun Yi Da Xue Xue Bao 24: 129-132, 2004.